Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Piotr GierlichLígia C Gomes-da-Silva

Abstract

Photodynamic therapy (PDT) is a promising cancer treatment which involves a photosensitizer (PS), light at a specific wavelength for PS activation and oxygen, which combine to elicit cell death. While the illumination required to activate a PS imparts a certain amount of selectivity to PDT treatments, poor tumor accumulation and cell internalization are still inherent properties of most intravenously administered PSs. As a result, common consequences of PDT include skin photosensitivity. To overcome the mentioned issues, PSs may be tailored to specifically target overexpressed biomarkers of tumors. This active targeting can be achieved by direct conjugation of the PS to a ligand with enhanced affinity for a target overexpressed on cancer cells and/or other cells of the tumor microenvironment. Alternatively, PSs may be incorporated into ligand-targeted nanocarriers, which may also encompass multi-functionalities, including diagnosis and therapy. In this review, we highlight the major advances in active targeting of PSs, either by means of ligand-derived bioconjugates or by exploiting ligand-targeting nanocarriers.

References

Aug 1, 1965·Journal of Molecular Biology·A D BanghamJ C Watkins
Oct 1, 1994·Journal of Photochemistry and Photobiology. B, Biology·M R Hamblin, E L Newman
Jan 1, 1994·Journal of Drug Targeting·C P Leamon, P S Low
Apr 22, 1993·International Journal of Cancer. Journal International Du Cancer·I SaikiI Azuma
Mar 28, 1996·Nature·R Pasqualini, E Ruoslahti
Dec 6, 2001·The International Journal of Biochemistry & Cell Biology·Laura PoloElena Reddi
Apr 10, 2002·American Journal of Physiology. Cell Physiology·Michael Papetti, Ira M Herman
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kimmo PorkkaErkki Ruoslahti
Jun 8, 2002·Nature Medicine·Pirjo LaakkonenErkki Ruoslahti
Oct 3, 2002·Nature Reviews. Cancer·Theresa M Allen
Nov 14, 2002·Pharmacological Reviews·Zhong Ming QianKwokping Ho
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Nov 26, 2003·The Journal of Cell Biology·Sven ChristianErkki Ruoslahti
Apr 20, 2004·Advanced Drug Delivery Reviews·Philip S Low, Asok C Antony
Jun 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pirjo LaakkonenErkki Ruoslahti
Jun 16, 2004·International Journal of Cancer. Journal International Du Cancer·Ping AnChengchao Shou
Jul 23, 2004·Journal of Medicinal Chemistry·Michael R DettyStephen J Wagner
Oct 30, 2004·Journal of Drug Targeting·Praveen K DubeyS P Vyas
Nov 3, 2004·Cancer Research·Omid C FarokhzadRobert Langer
Feb 3, 2005·Nature Reviews. Drug Discovery·Vladimir P Torchilin
Jul 21, 2005·Technology in Cancer Research & Treatment·Jaspreet K Vasir, Vinod Labhasetwar
Sep 10, 2005·Nature Biotechnology·Anna M Wu, Peter D Senter
Dec 2, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Zonghai LiJianren Gu
Jan 21, 2006·Nature Reviews. Drug Discovery·David SchramaJürgen C Becker
Jul 18, 2006·Biomolecular Engineering·Dwaine F Emerich, Christopher G Thanos
Nov 2, 2006·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Naram El-AkraJean-Pierre Souchard
Feb 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maneesh JainSurinder K Batra
Sep 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Derek W BartlettMark E Davis
Jan 24, 2008·Biochimica Et Biophysica Acta·Sara GoskGerd Bendas
May 27, 2008·Advanced Drug Delivery Reviews·Resham Bhattacharya, Priyabrata Mukherjee
Oct 9, 2008·Advanced Drug Delivery Reviews·James D ByrneLisa Brannon-Peppas
Nov 11, 2008·International Journal of Pharmaceutics·Jana PardeikeRainer H Müller
Nov 14, 2008·Journal of Cellular Physiology·Marlon R Schneider, Eckhard Wolf
Nov 18, 2008·Cancer Research·Gail D Lewis PhillipsMark X Sliwkowski
Mar 31, 2009·Expert Opinion on Drug Delivery·Manasi DasSanjeeb K Sahoo
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Tambet TeesaluErkki Ruoslahti
Oct 15, 2009·Molecular Cancer Therapeutics·Michael M Schmidt, K Dane Wittrup
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neil L Spector, Kimberly L Blackwell
Dec 8, 2009·Cancer Cell·Kazuki N SugaharaErkki Ruoslahti
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ji-Ho ParkMichael J Sailor

❮ Previous
Next ❯

Methods Mentioned

BETA
phage-display
phage display
xenografts
fluorescence imaging
xenograft
electron microscopy

Clinical Trials Mentioned

NCT02422979
NCT03769506

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Materials Science & Engineering. C, Materials for Biological Applications
Yonghe ZhangXiangdong Kong
Anti-cancer Agents in Medicinal Chemistry
Frédéric Schmitt, Lucienne Juillerat-Jeanneret
© 2021 Meta ULC. All rights reserved